Skip to main content
. 2011 May 1;5(3):681–686. doi: 10.1177/193229681100500322

Figure 1.

Figure 1

Mean plasma insulin profiles (A) with baseline correction (mean of the last three samples prior to injection) and mean blood glucose profiles (B) measured by the Biostator, obtained after SC injection of regular human insulin (dashed line), insulin lispro (dotted line), and an ultra-fast insulin (continuous line) in 18 patients with type 1 diabetes.